← Markets Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)
globenewswire_country_pl · Molecure ·
Molecure's Phase II KITE trial for OATD-01 in pulmonary sarcoidosis will continue without protocol changes following a positive IDMC review.